Quick Facts

• Primary Indications: Management of inflammatory skin conditions with a secondary bacterial infection.
• Target Conditions: Eczema and dermatitis, including atopic and contact dermatitis, where bacterial involvement is suspected or confirmed.
• Therapeutic Action: A combination to help address bacterial presence and support the easing of inflammation, redness, and discomfort.

---

Fucidine H is a prescription topical treatment indicated for the management of certain inflammatory skin conditions that are also associated with a secondary bacterial infection. The therapeutic utility is observed in conditions such as eczema and various forms of dermatitis, including atopic dermatitis and contact dermatitis.

This medication is applied when there is an established or suspected presence of bacteria sensitive to the antibiotic component. It serves to help address the bacterial involvement while simultaneously working to support the reduction of the characteristic swelling and inflammation commonly associated with these skin conditions. Furthermore, it may assist in easing the associated itching and redness, contributing to overall patient comfort. Treatment is generally reserved for short-term use.

Fucidine H is a prescription medication with official eligibility defined by regulatory restrictions, primarily due to its corticosteroid component.

Contraindicated Populations

Fucidine H is contraindicated and must not be used in individuals with a known hypersensitivity to fusidic acid, hydrocortisone, or any excipients. The medicine is strictly prohibited for use on primary skin infections caused by viruses (e.g., cold sores, chickenpox) or fungi (e.g., athlete's foot), and for certain inflammatory conditions including rosacea and perioral dermatitis. Use is also contraindicated for skin manifestations related to tuberculosis or syphilis.

---

Age and Conditional Use

Use is generally permitted for Adults and Children for short-term topical application. However, long-term continuous topical therapy must be avoided in all patients, particularly in infants and children, due to their increased susceptibility to systemic effects.

During pregnancy, use is permitted if clinically needed, but with the formal restriction that it must not be used extensively, in large amounts, or for prolonged periods. It is not recommended for application to compromised areas such as skin ulcers, acne vulgaris, or near the eyes, where contact should be avoided.

Interactions with other medicines and products

The official interaction profile for Fucidine H Cream, a combination of topical fusidic acid and hydrocortisone, is primarily defined by its route of administration and resulting minimal systemic absorption.

Official Regulatory Status

Regulatory authorities state that no formal interaction studies have been performed for this specific topical combination. Consequently, the prescribing information lists none known for co-administered systemic medicines.

Interactions with systemically administered medicinal products are considered minimal due to the low degree of absorption of both active ingredients through the skin. This classification means the label does not detail specific enzyme-mediated or transporter-based interactions, nor does it mandate timing separation rules for co-administered medicines.

Pharmacodynamic Interaction Caution

Interaction Type	Interacting Substance/Class	Official Caution
Pharmacodynamic (Class Effect)	Other topical or systemic corticosteroids	Potential for additive effects; risk of systemic corticosteroid effects (e.g., HPA axis suppression) is increased with co-administration.

This specific regulatory caution relates to the hydrocortisone component. Beyond this class effect, the official label does not document any specific interactions with food, alcohol, herbal products, or supplements. The label also does not list any medicines that are formally prohibited for co-administration.

Modulating the Bacterial Replication Cycle

The antibiotic component, Fusidic Acid, acts as a highly selective inhibitor of the bacterial Elongation Factor G ( EF-G) within susceptible microbial cells. This enzyme is required for translocating the ribosomal machinery during protein synthesis. By binding to the ribosome and preventing this essential translocation step, Fusidic Acid functionally arrests the assembly of new proteins, leading to microbial stasis and reducing the rate of bacterial cell division.

Suppressing the Host's Inflammatory Signaling

The Hydrocortisone component engages in targeted modulation of host processes by acting as an agonist for Intracellular Glucocorticoid Receptors ( GR). This molecular interaction leads to changes in gene expression, including the transactivation of anti-inflammatory proteins like Annexin A1. This protein, in turn, inhibits Phospholipase A2 ( PLA2), thereby limiting the precursors available for synthesizing inflammatory mediators such as prostaglandins and leukotrienes. This mechanism is crucial for suppressing local vasodilation and plasma leakage at the affected site.

Fucidine H is a dual-component medicine administered exclusively via the topical route. It is supplied as a cream formulated with 2% Fusidic Acid and 1% Hydrocortisone Acetate. The dosing regimen for this combination product involves applying a small quantity of the cream directly onto the affected skin area. This process establishes a localized administration protocol.

The cream is to be applied according to the dosing schedule, which is typically two or three times daily. Following administration, the cream must be gently massaged into the skin. A key procedural requirement is the necessity of washing hands after use, unless the hands themselves are the area requiring treatment.

Usage is strictly designated for short-term courses. The total treatment duration should generally not exceed 14 consecutive days. If no clinical improvement is observed within 7 days of consistent application, the treatment protocol must be reviewed. Furthermore, administration conditions require that the cream should not be used under occlusive dressings or bandages unless specifically advised, and prolonged application on the face or continuous use in pediatric patients must be avoided. If an application is missed, it should be applied promptly, but the dose must not be doubled to compensate for the omission.

Fucidine H: Recent Clinical Evidence

Fucidine H combines a fusidic acid, an antibiotic, with hydrocortisone, a mild corticosteroid. Recent research and clinical studies have focused on the combined product’s role in managing specific skin conditions where bacterial infection is present alongside inflammation.

---

Efficacy and Treatment Goals

Studies evaluating the fixed-dose combination generally aim to address two primary treatment goals: reducing bacterial proliferation and lessening inflammatory symptoms such as redness, swelling, and itching. Fusidic acid, the antimicrobial component, inhibits bacterial protein synthesis, while the hydrocortisone component provides local anti-inflammatory action.

Clinical trials have investigated the duration and extent of its effect when applied topically to conditions responsive to this dual therapy, such as infected eczema or dermatitis. A key observation across multiple studies is the influence of the combination in shortening the time to clinical improvement compared to using a single agent alone.

Safety and Comparative Use

Research has explored the tolerability profile of Fucidine H when used for the recommended short durations. The incidence of local adverse reactions, such as irritation or burning at the application site, is generally reported as low. Given that it contains a mild corticosteroid, studies typically support its use for limited periods to minimize the theoretical risk associated with prolonged corticosteroid exposure.

Comparative studies often evaluate this specific combination against other topical steroid-antibiotic preparations. Findings from these investigations provide data on differences in microbial sensitivity and anti-inflammatory power relative to the concentration of hydrocortisone used.

Key Studies & References

1. Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing (NICE Guideline NG190)

Common questions about Fucidine H (FAQ)

---

Q: Is Fucidine H the same as plain Fucidin?

No, according to regulatory documents, Fucidine H is a combination product that contains two active ingredients: the antibiotic fusidic acid and the corticosteroid hydrocortisone. Plain Fucidin contains only the antibiotic fusidic acid. The addition of hydrocortisone in Fucidine H provides the anti-inflammatory component, which is intended to be used alongside the antibiotic action of fusidic acid.

---

Q: Does Fucidine H treat fungal infections or just bacterial ones?

Fucidine H is indicated for conditions involving bacterial infection because it contains the antibiotic fusidic acid. Official product information states it is contraindicated and should not be used on primary skin infections caused by viruses or fungi, such as cold sores or athlete's foot.

---

Q: Can Fucidine H be used near the eyes or mouth?

Official guidance advises that the cream should be used with caution near the eye because contact could potentially lead to issues like glaucoma (raised pressure in the eye). The product is also contraindicated for use on certain inflammatory conditions around the mouth, specifically perioral dermatitis.

---

Q: Is Fucidine H safe to use while breastfeeding?

Fucidine H can be used during breastfeeding according to official product information. This is based on regulatory information indicating that systemic exposure is anticipated to be negligible following topical application. However, it is recommended to avoid applying the cream directly to the breast area.

---

Q: What is the difference between Fucidine H and other steroid-containing creams?

Fucidine H is a unique combination product that pairs the antibiotic fusidic acid with the anti-inflammatory steroid hydrocortisone. Many other steroid-containing creams contain only the steroid component, or they may contain a different type or strength of steroid and antibiotic. The combination in Fucidine H is intended for use in conditions where there is both an infection and inflammation.

---

Q: Is Fucidine H a high-strength or low-strength steroid?

The corticosteroid component in Fucidine H is hydrocortisone, which is generally classified in regulatory documents as a mild or low-potency topical steroid. Its purpose is to provide localized anti-inflammatory action.

---

Q: What does the 'H' stand for in Fucidine H?

The 'H' in the product name is associated with the active ingredient hydrocortisone. This is the corticosteroid component that works to reduce inflammation, and it is combined with the antibiotic fusidic acid.

---

Q: Can Fucidine H be applied to large areas of the body?

Regulatory guidance advises against using the cream extensively, in large amounts, or for prolonged periods. This caution is in place due to the potential for systemic absorption of the steroid component and related class effects, especially in children.

---

Q: Why does Fucidine H need a prescription?

Fucidine H is designated as a Product Subject to Medical Prescription. The need for a prescription is related to regulatory requirements for managing the risks associated with both an antibiotic (e.g., resistance) and a corticosteroid (e.g., systemic effects).

---

Q: Does using Fucidine H affect how I use other topical medications?

Official warnings specifically advise caution when co-administering Fucidine H with other topical or systemic corticosteroids due to the potential for additive effects. There is no specific regulatory guidance detailed regarding the timing of non-corticosteroid topical products.

---

Q: Is Fucidine H greasy or easily absorbed?

Fucidine H is formulated as a cream, which typically contains excipients like paraffin and cetyl alcohol. In terms of absorption into the body, regulatory documents note that systemic exposure is considered negligible following topical application to a limited skin area.

---

Q: Is a rebound effect possible if Fucidine H is stopped suddenly?

The phenomenon known as a withdrawal reaction, which can appear as a rebound effect after discontinuing the product, is documented as a potential adverse reaction in regulatory documents. This reaction is listed with a frequency that is not known based on available reports.

---

Q: Is it normal for a rash to clear up then return shortly after stopping Fucidine H?

The return of a condition days to weeks after a successful treatment is a pattern noted by prescribers that can raise suspicion of a topical steroid withdrawal reaction. Official warnings advise against stopping topical steroids suddenly after prolonged use.

---

Q: Are there specific food or drink interactions with Fucidine H?

According to the official product information, the label does not document any specific interactions between Fucidine H and food, alcohol, herbal products, or supplements. Interactions are considered minimal due to the drug's topical route and low systemic absorption.

---

Q: How does Fucidine H differ from hydrocortisone-only creams?

Fucidine H is a combination product that includes the antibiotic fusidic acid in addition to the anti-inflammatory steroid hydrocortisone. Hydrocortisone-only creams contain only the steroid component, meaning they provide anti-inflammatory action but do not treat bacterial infections.

---

Q: Does Fucidine H contain parabens or other common allergens?

Official documentation lists the excipients (inactive ingredients) in the cream. Fucidine H does not contain parabens. However, it does contain ingredients such as cetyl alcohol and potassium sorbate, which are noted in regulatory information as potentially causing local skin reactions like contact dermatitis.

Fucidine H Cream must be stored in accordance with regulatory instructions to maintain its stability and ensure safety.

Official Storage and Handling Requirements

Requirement	Constraint
Maximum Temperature	Store at a temperature not exceeding 30°C.
In-Use Stability	Discard the cream 3 months after first opening the tube.
Child Safety	Keep out of the sight and reach of children.
Special Handling	Patients must be aware that fabric contaminated with the cream poses a severe fire hazard; avoid naked flames and smoking.

Disposal

Expired or unused product must not be thrown away with household waste or flushed down the toilet. Disposal should be completed in accordance with local regulations for pharmaceutical waste, typically by consulting a pharmacist.